Department of Oncology-Pathology
The Department of Oncology-Pathology conducts basic, translational and clinical research and educational activities related to cancer.
Lars Holmgren on twitter
Lars Holmgren on twitter
Follow the chair of the department of Oncology-Pathology Lars Holmgren on twitter.
Three researchers at OnkPat receives funding from the Swedish Cancer Society
Linda Sofie Lindström receives the Senior investigator award for her research project entitled ”Identification of late risk mechanisms for fatal breast cancer disease”, Lotta Hansson receives the Senior Clinical Investigator Award for her projekt entitled ”Cronic lymfocytic leukemia (CLL): real world effects of precision medicine and clinical/immunological studies in CLL patients post Covid-19 infection and vaccination.” Eva Onjukka receives the Fellowship within radiotherapy research for her project ”Real world-data för evidensbaserad stråldosplanering vid huvud/halscancer.”
The cancer researcher who fled from the war in Ukraine
Viktoriya Tsuber fled from Ukraine and her hometown Poltava just when the war started. Just a few days after her flight via Poland, she started working as a researcher at Karolinska Institutet in Professor Thomas Helledays lab at the department of Oncology-Pathology.
A new digital tool for an efficient implementation of individualized cancer treatment
A new digital tool for an efficient implementation of individualized cancer treatment
David Tamborero and Janne Lehtiö at OnkPat together with colleagues around Europe has published an article in Nature Cancer. There they describe The Molecular Tumor Board Portal which is a system that identifies the specific genomic alterations that are driving a patient's tumor and associate these results with available anti-cancer therapies. This system can allow the use of new technologies and emerging biomarkers that can further improve the selection of the most appropriate treatment for each patient.
The RadioVal project was granted nearly 6 million euro by the Horizon Europe program
Fredrik Strand and Theodoros Foukakis of the KI OnkPat department form for the Swedish participation in the consortium. RadioVal is the first multicenter multifaceted study of radiomics-driven clinical validation of neoadjuvant therapy response prediction. The project builds on tools and image repositories created in five EU-financed projects from the AI for Health Imaging network (AI4HI). To evaluate usability and transferrability, the validation will take place across eight centers in Sweden, Austria, Spain, Poland, Croatia, Argentina, Egypt and Turkey.
New conferment for professor Lars Egevad
New conferment for professor Lars Egevad
Professor Lars Egevad at the Department of Oncology-Pathology has been conferred Honorary Fellow by the Royal College of Pathologists of Australasia.
Several researchers at OnkPat receives funding from the Swedish Childhood Cancer Fund
Martin Enge receives 3,9 million SEK, Andreas Lundqvist 1,2 million SEK, Georgios Rassidakis 2,4 million SEK, Charlotte Rolny 1 million SEK and Thomas Helleday 4,5 million SEK.
Study shows how digital and molecular data can be integrated and used to improve health
Study shows how digital and molecular data can be integrated and used to improve health
Analysing molecular characteristics and their variation during lifestyle changes, by combining digital tools, classical laboratory tests and new biomolecular measurements, could enable individualised prevention of disease. This is according to a new study from OnkPat and the University of Helsinki in Finland published in the journal Cell Systems. The researchers show what a proactive healthcare model could comprise and how it could help in maintaining good health.